New Phase 3 trial: A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the Day — Idorsia Pharmaceuticals Ltd.
Why now
Thesis: Insomnia drug trial adds to Idorsia pipeline
Catalyst to watch: Trial initiation and enrollment
Main risk: Trial delays or enrollment shortfalls
Why it matters
A new insomnia trial for daridorexant signals continued development for Idorsia.
Details
Sponsor: Idorsia Pharmaceuticals Ltd.; Status: Not Yet Recruiting; Conditions: Insomia Disorder; Interventions: Daridorexant, Placebo; Enrollment: 344 (estimated); First posted: 2026-09-28; NCT: NCT07843329
Related assets & topics
HealthcareSources
- clinicaltrials · 2026-09-28 12:00 UTC